KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Other financing activities (2016 - 2022)

Abbott Laboratories' Other financing activities history spans 7 years, with the latest figure at $324.0 million for Q1 2022.

  • On a quarterly basis, Other financing activities rose 6.58% to $324.0 million in Q1 2022 year-over-year; TTM through Sep 2025 was $324.0 million, a 427.27% increase, with the full-year FY2025 number at -$82.0 million, changed N/A from a year prior.
  • Other financing activities hit $324.0 million in Q1 2022 for Abbott Laboratories, up from -$536.0 million in the prior quarter.
  • Over the last five years, Other financing activities for ABT hit a ceiling of $324.0 million in Q1 2022 and a floor of -$536.0 million in Q4 2021.
  • Historically, Other financing activities has averaged $110.9 million across 5 years, with a median of $105.5 million in 2019.
  • Biggest five-year swings in Other financing activities: crashed 79.65% in 2018 and later increased 24.08% in 2021.
  • Tracing ABT's Other financing activities over 5 years: stood at $81.0 million in 2018, then rose by 4.94% to $85.0 million in 2019, then rose by 18.82% to $101.0 million in 2020, then plummeted by 630.69% to -$536.0 million in 2021, then soared by 160.45% to $324.0 million in 2022.
  • Business Quant data shows Other financing activities for ABT at $324.0 million in Q1 2022, -$536.0 million in Q4 2021, and $113.0 million in Q3 2021.